| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2876502 | The Annals of Thoracic Surgery | 2011 | 8 Pages |
Abstract
Interleukin-19 reduces T-cell responses and promotes the regulatory activity of CD4+ T cells. Induced IL-19 in patients undergoing CABG with CPB contributes to cell-mediated immunosuppression.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ching-Hua PhD, Bor-Chih MD, Chuan-Chih MD, Hung-Wei MS, Jhi-Joung MD, PhD, Ming-Shi PhD, Chung-Hsi MD, PhD,